UTMC: The Painless Approach to SUD


The Opioid Use Epidemic continues to claim over a hundred thousand lives per year in the United States. The standard of care for Opioid Use Disorder is treatment with buprenorphine accompanied by mental health therapy and support. Due to continued stigma, bias, misunderstanding, and misinformation, there continues to be hesitancy among medical providers and pharmacists when prescribing and dispensing this medication. In order to combat all of these factors we have developed this eight-hour series to properly educate as many healthcare providers as possible and support staff on the factors associated with addiction, the development of the disease, the treatment of the disease, and various other areas that pertain to the disease. This series will also cover other addictions (methamphetamine and alcohol) and will meet the DEA's MATE Act requirements.

Date: Aug 7, 2024 01:00 AM - Sep 25, 2024 01:00 AM

Fee

$0.00

CE Hours

2.00

CE Units

0.200

Registration closes on Oct 25, 2024 12:00 AM

Activity Type

Knowledge

Target Audience(s)

Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

Registration start from
08/07/2024  

Objectives

  • Paraphrase the neurobiology of addiction.
  • Recognize the chronic-disease component of addiction.
  • Name the systems-based interactions associated with addiction.
  • Explain why we should treat addiction.
  • Restate addiction knowledge to colleagues.

Speaker(s)/Author(s)

Ryan Alexander

Activity Number

0064-9999-24-091-L08-P/T
Date: 08/07/24
Time: 01:00 AM - 01:00 AM

CE Hours

1.00
Registration start from
08/07/2024  

 

Registration start from
08/07/2024  

Speaker(s)/Author(s)

Bryan West

John Robinson

Trey Parrish

Activity Number

0064-9999-24-092-L08-P/T
Date: 08/14/24
Time: 01:00 AM - 01:00 AM

CE Hours

1.00
Registration start from
08/07/2024